http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0579766-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56666880a5e2b7703e98a4f9b2d9daf6 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 |
filingDate | 1992-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f65c00509844c5a920b9872366afb354 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6471ab0fdfb65cad09a79375edd331ba |
publicationDate | 1994-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0579766-A1 |
titleOfInvention | N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders |
abstract | A class of N-arylheteroarylalkyl imidazol-2-one compounds for use in the treatment of circulatory disorders such as hypertension and congestive heart failure is described. Compounds of particular interest are angiotensin II antagonists of formula (I) in which A is selected from (a), (b), (c), (d), (e) and (f), where m is one; where R1 is chosen from methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, 4-methylbutyl, 2-ethylbutyl, n-pentyl, neopentyl, phenyl, methylphenyl, difluorophenyl, benzyl , phenethyl, cyclohexyl, cyclohexylmethyl, cyclohexylethyl, cyclohexanoyl, 1-oxo-2-cyclohexylethyl, benzoyl, 1-oxo-2-phenethyl, 1-oxopropyl, 1-oxobutyl, 1-oxopentyl and 2-hydroxybutyl; where R0 is hydrido; where R2 is chosen from methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, isopentyl, neopentyl, phenyl, benzyl, phenethyl, cyclohexyl, cyclohexylmethyl, propylthio, butylthio , and hydroxyalkyl; where R3, R4, R6, R7, R8, R9, R10 and R11 are each hydrido and R5 must be chosen from COOH, SH, PO3H2, SO3H, CONHNH2, CONHNHSO2CF3, OH, (g), (h) and (i) where R42 and R43 are each independently selected from chloro, cyano, nitro, trifluoromethyl, methoxycarbonyl and trifluoromethylsulfonyl; or a tautomer thereof or a pharmaceutically acceptable salt thereof. |
priorityDate | 1991-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 2401.